156101-08-5

Basic information

• Product Name: Erinacine A Erinacin A
• Synonyms: Erinacine A Erinacin A
• CAS NO: 156101-08-5
• Molecular Formula: C25H36O6
• Molecular Weight: 432.54974
• Mol File: 156101-08-5.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 610.8±55.0 °C(Predicted)
• Appearance: /
• Density: 1.24±0.1 g/cm3(Predicted)
• PKA: 13.01±0.70(Predicted)
• CAS DataBase Reference: Erinacine A Erinacin A(CAS DataBase Reference)
• NIST Chemistry Reference: Erinacine A Erinacin A(156101-08-5)
• EPA Substance Registry System: Erinacine A Erinacin A(156101-08-5)

Safety Data

• Hazardous Substances Data: 156101-08-5(Hazardous Substances Data)

Usage

Description

Erinacine A, also known as (+)-Erinacin A, is a diterpenoid derivative that has been isolated from the mushroom Hericium erinaceum. Erinacine A
Erinacin A has been found to possess neuroprotective properties and is known for its ability to increase the catecholamine and nerve growth factor (NGF) content in the central nervous system of rats.

Uses

Used in Pharmaceutical Industry:
Erinacine A is used as a neuroprotective agent for its ability to increase the catecholamine and nerve growth factor (NGF) content in the central nervous system of rats. This makes it a promising candidate for the development of treatments for neurological disorders and conditions related to cognitive decline.
Used in Neurodegenerative Disease Treatment:
Erinacine A is used as a potential therapeutic agent for neurodegenerative diseases such as Alzheimer's, Parkinson's, and other conditions characterized by the loss of nerve cells and cognitive decline. Its ability to increase catecholamine and NGF content in the central nervous system may help in slowing down or preventing the progression of these diseases.
Used in Cognitive Enhancement:
Erinacine A is used as a cognitive enhancer due to its neuroprotective properties and its ability to increase the catecholamine and nerve growth factor (NGF) content in the central nervous system. This may help improve memory, learning, and overall cognitive function in individuals experiencing age-related cognitive decline or other cognitive impairments.